Last A$2.44 AUD
Change Today -0.005 / -0.20%
Volume 914.1K
HSO On Other Exchanges
As of 9:45 PM 09/17/14 All times are local (Market data is delayed by at least 15 minutes).

healthscope ltd (HSO) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/17/14 - A$2.45
52 Week Low
07/28/14 - A$2.09
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for HEALTHSCOPE LTD (HSO)

Related News

No related news articles were found.

healthscope ltd (HSO) Related Businessweek News

No Related Businessweek News Found

healthscope ltd (HSO) Details

Healthscope Limited provides private health care services. The company’s Hospitals segment offers medical and surgical services in the fields of intensive care, maternity, cardiac, orthopaedics, urology, oral, gynaecology, endoscopy, vascular, and ear, nose, and throat surgery, as well as provides general, plastic, other specialist and day surgery. This segment also provides treatment for anxiety, depression, schizophrenia, post-traumatic stress, eating disorders, alcohol and drug addiction, and obsessive compulsive disorders; and rehabilitation services for patients with acquired brain injury, musculoskeletal injuries, cardiac and stroke, and pain management. It operates 44 private hospitals with approximately 4,400 beds, including 31 acute hospitals, 7 psychiatric hospitals, and 6 rehabilitation and extended care facilities, as well as operates independent living housing facilities. Its International Pathology segment provides various pathology services primarily under the Labtests, SCL, and Northland brands; and general practitioner, specialist, hospital, and corporate screening services, as well as offers women’s and children’s health services. It operates 13 laboratories in New Zealand; 26 laboratories in Malaysia; and 1 central laboratory in Singapore, as well as manages 1 laboratory in Vietnam. The company’s Australian Pathology segment provides anatomical, biochemistry, haematology, microbiology, and molecular pathology services; and general practice management services, as well as operates one specialist breast diagnostic clinic in Sydney. As of May 19, 2014, it operated 578 collection centers and 69 accredited laboratories; and 46 medical centers and 11 specialist skin cancer clinics. The company was formerly known as Healthscope Hospitals Holdings Pty. Ltd. Healthscope Limited was founded in 1985 and is based in Melbourne, Australia. Healthscope Limited operates as a subsidiary of Healthscope Group.

Founded in 1985

healthscope ltd (HSO) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

healthscope ltd (HSO) Key Developments

Healthscope Limited Reports Audited Earnings Results for the Year Ended June 30, 2014; Provides Earnings Guidance for the Full Year 2015

Healthscope Limited reported audited earnings results for the year ended June 30, 2014. For the period, the company's revenue was AUD 2,326.1 million against AUD 2,212.5 million a year ago. EBITDA was AUD 357.3 million against AUD 327.9 million a year ago. EBIT was AUD 262.3 million against AUD 235.9 million a year ago. Loss before tax was AUD 24.1 million against AUD 114.9 million a year ago. Net loss after tax was AUD 19.3 million against AUD 117.3 million a year ago. Cash inflows from operations of AUD 365.6 million, an increase of 17.6% on 2013. Net debt as on June 30, 2014 was AUD 1,561.5 million. Loss before income tax was AUD 24.117 million against AUD 114.940 million a year ago. Net cash provided by operating activities was AUD 157.489 million against AUD 110.160 million a year ago. Payments for property, plant and equipment was AUD 70.036 million against AUD 71.556 million a year ago. The company is on track to deliver the 2015 financial forecasts included in the Prospectus of Healthscope Limited dated June 30, 2014 which include an 2015 operating EBITDA of AUD 387.3 million and 2015 operating EBIT of AUD 284.7 million.

Updates On Listing Plans Of Healthscope- Reports

TPG Capital, L.P. and The Carlyle Group LP (NasdaqGS:CG) are planning to raise about AUD 2.5 billion in an initial public offering for Healthscope Limited and are lining up cornerstone investors before filing the prospectus by end-June or early July 2014, Reuters reported citing a source with direct knowledge of the plan. An external spokeswoman representing Healthscope Limited, TPG Capital, L.P. and The Carlyle Group LP declined to comment.

Fosun Interested In Healthscope

Shanghai Fosun High Technology (Group) Co., Ltd. is interested in acquiring Healthscope Limited, the Australian Financial Review reported. Patrick Zhong, Head of Global Investments at Fosun, told Australian Financial Review that the company saw a great opportunity for Healthscope to develop in China. Zhong said, "Healthscope is a pretty large company, but think about if they had the same position in China (as in Australia). The counterpart of Healthscope would be huge - 10 times larger potentially. This is the opportunity."


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HSO:AU A$2.44 AUD -0.005

HSO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for HSO.
View Industry Companies

Industry Analysis


Industry Average

Valuation HSO Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HEALTHSCOPE LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at